What We Do
Flarin Holdings Limited is an independent company dedicated to the progressive international commercialisation of Flarin.
What is Flarin?
Flarin is the first and only lipid formulated ibuprofen analgesic. It is widely patented internationally and is clinically proven to be as effective as twice the dose of standard ibuprofen. Flarin 200 mg soft capsules and Flarin Joint & Muscular Pain Relief 200 mg soft capsules are indicated for a wide range of symptoms including relief of rheumatic pain or muscular pain, back pain. Flarin 200 mg soft capsules is also indicated for the pain of non-serious arthritic conditions caused by swelling, stiffness and inflammation. Always read the label. For further details about the Flarin product see www.flarin.co.uk .
Our History and Ownership
Flarin was developed and launched in the UK by our predecessor company infirst Healthcare Ltd. In 2019 the Flarin business and associated intellectual property was demerged into infirst Limited which is 100% owned by Flarin Holdings Limited.
The current owners of Flarin Holdings Limited include corporate shareholdings held by ITV plc, Hambro Perks Ltd and Biocopea Ltd and a large number of private holdings including shareholders introduced by IW Capital Ltd.